• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • New Registration Requirements for Submitting the Clinical Trial Data of Medical Device

New Registration Requirements for Submitting the Clinical Trial Data of Medical Device

Clinical Trials GMP management
Monday, 20 December 2021 / Published in Medical Device, News, NMPA Registration in China

New Registration Requirements for Submitting the Clinical Trial Data of Medical Device

On November 25, 2021, the NMPA (National Medical Products Administration) issued (No.91 – 2021) the technical review guidelines for the registration of medical devices and IVDs concerning the clinical trial data submission requirements.

Highlights

  • Medical Device Clinical Trial Data Submission
    • Scope of application: Applicable to clinical trials of medical devices for the purpose of product registration, including overseas clinical trials; Not applicable to clinical trials of In Vitro Diagnostics.
    • Basic principles of data submission: Authenticity, traceability and readability.
    • Submission form requirements: Clinical trial data of medical devices usually include original database, analytical database, explanatory documents and procedure code. The guideline provides requirements and provisions on the specific format and content of each application data. Applicants are encouraged to submit Data in accordance with the Clinical Data Interchange Standards Consortium (CDISC) Standards. The original database, analysis database, illustrative files, and program code are placed in four separate folders.
  • In Vitro Diagnostics Clinical Trial Data Submission
    • Scope of application: Applicable to in vitro diagnostics clinical trial carried out for the purpose of product registration, including overseas clinical trial.
    • Basic principles of data submission: authenticity, traceability, readability and comprehensiveness of data.
    • Requirements of Clinical trial database contents: In general, clinical trial database content shall include information about subjects and test information of clinical trial samples. The guideline specifies data information that should be included in different types of clinical trial design.
    • Requirements of submission form: Applications relating to in vitro diagnostic clinical trial data usually include the original database, analytical database, explanatory documentation and procedure code (if any). The guidelines specify the specific format and content of each application. Applicants are encouraged to submit Data in accordance with the Clinical Data Interchange Standards Consortium (CDISC) Standards. The original database, analysis database, illustrative files, and program code (if any) should be placed in four separate folders.

By Alice Liu and Jacky Li. Cisema regularly support clinical trials in China as a CRO. For our clinical trial protocol and preparatory studies, or more details about full clinical trial support in China, please inform us.

Tagged under: clinical trial data, Clinical Trials

What you can read next

Medical device classification catalogue
Medical Device Classification Catalogue Changes in March 2022
Extension of Exemption List for Medical Devices and IVDs soon
New Top-Level China Medical Device/IVD Law “Order 739” Now In Force

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.